WELCOME
Welcome to the Respiratory International Research Group
Latest Research
Research Focus
Our initiative is dedicated to the study of critical respiratory conditions affected by pan-viral agents (COVID-19, RSV, influenza) and chemical exposures (EVALI), striving to provide healthcare professionals with in-depth analyses and up-to-date clinical insights.
Our Focus Areas
COVID-19
Our ongoing research into COVID-19 addresses its long-term effects on lung health and explores effective treatment options.
RSV
Research on RSV focuses on its impact on both pediatric and adult populations and potential therapeutic approaches.
Influenza
We study influenza’s evolution and its effects on respiratory function, contributing to better prevention strategies.
EVALI
Our work on EVALI investigates its causes and ways to improve patient outcomes through targeted interventions.
